United States · Bill · HR
H.R. 3605 (98th)
Drug Price Competition and Patent Term Restoration Act of 1984
Introduced
19 July 1983
Last action
6 September 1984 · Floor
Status
House Incorporated this Measure (Amended) in S.1538 as an Amendment.
Sponsors
Rep. Waxman, Henry A. [D-CA-33], Rep. Madigan, Edward R. [R-IL-15], Sen. Wyden, Ron [D-OR], Rep. Sikorski, Gerry E. [D-MN-6], Sen. Wirth, Timothy [D-CO], Rep. Leland, Mickey [D-TX-18], Sen. Markey, Edward J. [D-MA], Rep. Swift, Al [D-WA-2], Rep. Bryant, John W. [D-TX-5], Rep. Weiss, Ted [D-NY-17], Sen. Gore, Albert, Jr. [D-TN], Rep. Kaptur, Marcy [D-OH-9], Rep. Owens, Major R. [D-NY-11], Rep. Martinez, Matthew G. [D-CA-31], Rep. Bedell, Berkley W. [D-IA-6], Rep. Synar, Mike [D-OK-2]
Subjects
Healthcare
Source updated
3 June 2026
Summary
Drug Price Competition Act of 1983 - Amends the Federal Food, Drug, and Cosmetic Act to exempt from Food and Drug Administration (FDA) clinical application requirements new drugs that are the same as previously approved new drugs (extends FDA abbreviated drug application procedures to post-1962 new generic drugs).
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 July 1983
Introduced
Referred to House Committee on Energy and Commerce.
Source: IntroReferral
19 July 1983
Introduced
Introduced in House
Source: IntroReferral
19 July 1983
Introduced
Introduced in House
Source: IntroReferral
21 July 1983
Referred
Referred to Subcommittee on Health and the Environment.
Source: Committee
25 July 1983
Committee
Subcommittee Hearings Held.
Source: Committee
2 August 1983
Committee
Forwarded by Subcommittee to Full Committee.
Source: Committee
2 August 1983
Committee
Subcommittee Consideration and Mark-up Session Held.
Source: Committee
12 June 1984
Reported
Ordered to be Reported (Amended) by Voice Vote.
Source: Committee
12 June 1984
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
21 June 1984
Introduced
Referred to House Committee on The Judiciary Sequentially, for a Period Ending not Later than Aug 1, 84.
Source: IntroReferral
21 June 1984
Reported
Reported to House (Amended) by House Committee on Energy and Commerce. Report No: 98-857 (Part I).
Source: Committee
21 June 1984
Reported
Reported to House (Amended) by House Committee on Energy and Commerce. Report No: 98-857 (Part I).
Source: Committee
25 June 1984
Referred
Referred to Subcommittee on Courts, Civil Liberties, and the Administration of Justice.
Source: Committee
27 June 1984
Committee
Subcommittee Hearings Held.
Source: Committee
25 July 1984
Committee
Forwarded by Subcommittee to Full Committee (Amended).
Source: Committee
25 July 1984
Committee
Subcommittee Consideration and Mark-up Session Held.
Source: Committee
31 July 1984
Reported
Ordered to be Reported (Amended).
Source: Committee
31 July 1984
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
1 August 1984
Calendars
Placed on Union Calendar No: 531.
Source: Calendars
1 August 1984
Reported
Reported to House (Amended) by House Committee on The Judiciary. Report No: 98-857 (Part II).
Source: Committee
1 August 1984
Reported
Reported to House (Amended) by House Committee on The Judiciary. Report No: 98-857 (Part II).
Source: Committee
8 August 1984
Floor
Called up by House by Rule.
Source: Floor
8 August 1984
Passed
Rule Passed House.
Source: Floor
8 August 1984
Reported
Rules Committee Resolution H.Res.569 Reported to House.
Source: Floor
8 August 1984
Floor
Committee on Rules Granted an Open Rule Providing Two Hours of General Debate; Making in Order the Energy and Commerce Committee Amendment in the Nature of a Substitute now Printed in the Bill as Original Text for the Purposes of Amendment; Waiving all Points of Order Against the Amendment for Failure to Comply with the Provisions of Clause 7, Rule XVI.
Source: Floor
6 September 1984
Floor
Laid on Table in House by Voice Vote.
Source: Floor
6 September 1984
Vote
Passed House (Amended) by Yea-Nay Vote: 362 - 0 (Record Vote No: 379).
Source: Floor
6 September 1984
Vote
Passed/agreed to in House: Passed House (Amended) by Yea-Nay Vote: 362 - 0 (Record Vote No: 379).
Source: Floor
6 September 1984
Passed
House Agreed to Amendments Adopted by the Committee of the Whole.
Source: Floor
6 September 1984
Floor
Committee Amendment in the Nature of a Substitute Considered as an Original Bill for the Purpose of Amendment.
Source: Floor
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
4 official files
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Passed House amended
summary · EN · 6 September 1984
Reported to House amended, Part II
summary · EN · 1 August 1984
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported to House amended, Part I
summary · EN · 21 June 1984
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 19 July 1983
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Waxman, Henry A. [D-CA-33] · D · Sponsor
- Rep. Madigan, Edward R. [R-IL-15] · R · Sponsor
- Sen. Wyden, Ron [D-OR] · D · Sponsor
- Rep. Sikorski, Gerry E. [D-MN-6] · D · Sponsor
- Sen. Wirth, Timothy [D-CO] · D · Sponsor
- Rep. Leland, Mickey [D-TX-18] · D · Sponsor
- Sen. Markey, Edward J. [D-MA] · D · Sponsor
- Rep. Swift, Al [D-WA-2] · D · Sponsor
- Rep. Bryant, John W. [D-TX-5] · D · Sponsor
- Rep. Weiss, Ted [D-NY-17] · D · Sponsor
- Sen. Gore, Albert, Jr. [D-TN] · D · Cosponsor
- Rep. Kaptur, Marcy [D-OH-9] · D · Cosponsor
- Rep. Owens, Major R. [D-NY-11] · D · Cosponsor
- Rep. Martinez, Matthew G. [D-CA-31] · D · Cosponsor
- Rep. Bedell, Berkley W. [D-IA-6] · D · Cosponsor
- Rep. Synar, Mike [D-OK-2] · D · Cosponsor
- · hsju00 · Standing
- · hsif00 · Standing
Related records
- related to → A resolution providing for the consideration of the bill (H.R. 3605) to amend the Federal Food, Drug, and Cosmetic Act to authorize an abbreviated new drug application under section 505 of that Act for generic new drugs equivalent to approved new drugs.
- related to ← An act to amend the Federal Food, Drug, and Cosmetic Act to revise the procedures for new drug applications, to amend title 35, United States Code, to authorize the extension of the patents for certain regulated products, and for other purposes.
- amends ← An amendment to strike the language of title I, substituting the language of S. 2926, Drug Price Competition and Patent Term Restoration Act of 1984. Title I is entitled "Abbreviated New Drug Applications".
- amends ← An amendment to refquire country of origin labels on domestically produced, as well as imported, merchandise as regards to their textile origin. The amendment specifies that the item and its package must be labeled, or the package must be transparent such that the label on the item is clearly visible. In the case of hosiery items only the package must be labeled. Labels must be on the collars of items with collars. The amendment has language for "textile fiber products" and for wool products. Products will be considered falsely or deceptively presented if they do not conform to these standards. Also mail order catalogues for such items must state the country of origin of the fiber.
- amends ← An amendment to strike the language if Title II and substitute the language of Title II of S.2936, Drug Price Competition and Patent Term Restoration Act of 1984. Title II is entitled "Patent Extension".
- amends ← An amendment to the Waxman amendment to change the period for approval of generic drugs from 30 months to 18 months.
- amends ← An amendment to the Waxman amendment to specify that the bill applies only to prescription drugs.
- amends ← An amendment to the Derrick amendment, as amended, to change the effective date of the Title III (Fiber Content Provisions) from 90 days to 180 days from the date of the bill's enactment.
- amends ← An amendment to the Derrick amendment, as amended, to strike language that requires that textile fiber products advertised in mail order promotional materials must show if they are imported. It retains language that requires the material to show the origin of items when they are made in the U.S.
Showing 9 of 12 related records.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/98th-congress/house-bill/3605
- Open data entity: https://api.congress.gov/v3/bill/98/hr/3605
- us · 98-hr-3605 · source updated 3 June 2026